These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8548112)

  • 1. Parenteral antiarrhythmic drug therapy in ventricular tachycardia/ventricular fibrillation: evolving role of class III agents--focus on amiodarone.
    Scheinman MM
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):914-9. PubMed ID: 8548112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone: an emergency medicine perspective.
    Taylor SE
    Emerg Med (Fremantle); 2002 Dec; 14(4):422-9. PubMed ID: 12534486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardia.
    Gibson AE; Jaeschke R
    Pol Arch Med Wewn; 2016 Oct; 126(10):791-792. PubMed ID: 27872454
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
    Anderson JL
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous amiodarone.
    Dimens Crit Care Nurs; 2000; 19(1):29. PubMed ID: 10876483
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous amiodarone for ventricular arrhythmias: overview and clinical use.
    Gonzalez ER; Kannewurf BS; Ornato JP
    Resuscitation; 1998; 39(1-2):33-42. PubMed ID: 9918445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone.
    Yalçinkaya S; Kumbasar SD; Semiz E; Tosun Z; Paksoy N
    J Electrocardiol; 1997 Apr; 30(2):147-9. PubMed ID: 9141611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
    Wood MK
    Ann Thorac Surg; 1996 Jun; 61(6):1874. PubMed ID: 8651814
    [No Abstract]   [Full Text] [Related]  

  • 19. Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.
    Yoshie K; Tomita T; Takeuchi T; Okada A; Miura T; Motoki H; Ikeda U
    Int J Cardiol; 2014 Oct; 176(3):936-40. PubMed ID: 25201023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous amiodarone.
    Kowey PR; Marinchak RA; Rials SJ; Filart RA
    J Am Coll Cardiol; 1997 May; 29(6):1190-8. PubMed ID: 9137212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.